JUVENESCENCE
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profoun... d implications on all sectors of society, and in particular healthcare, education, insurance, and leisure. The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging. Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence.
JUVENESCENCE
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Status:
Active
Contact:
441624639396
Email Addresses:
[email protected]
Total Funding:
219.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Oregon Region CSC Global DNS
Similar Organizations
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Ultivue
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-04 | Portage Pharmaceuticals | Portage Pharmaceuticals acquired by Juvenescence | N/A |
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Series B - Juvenescence
Grok Ventures
Grok Ventures investment in Series B - Juvenescence
IPGL
IPGL investment in Series B - Juvenescence
Explorer Equity Group
Explorer Equity Group investment in Series B - Juvenescence
Oryx Ventures
Oryx Ventures investment in Series B - Juvenescence
Kingsley Advani
Kingsley Advani investment in Series B - Juvenescence
Formic Ventures
Formic Ventures investment in Series B - Juvenescence
Andrew Banks
Andrew Banks investment in Seed Round - Juvenescence
Apeiron Investment Group
Apeiron Investment Group investment in Seed Round - Juvenescence
Karim Hakimzadeh
Karim Hakimzadeh investment in Seed Round - Juvenescence
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-21 | MDI Therapeutics | Juvenescence investment in Series A - MDI Therapeutics | 9 M USD |
| 2020-12-30 | LyGenesis | Juvenescence investment in Convertible Note - LyGenesis | 11 M USD |
| 2019-10-21 | LyGenesis | Juvenescence investment in Debt Financing - LyGenesis | 4 M USD |
| 2019-05-28 | Souvien Therapeutics | Juvenescence investment in Venture Round - Souvien Therapeutics | 3.5 M USD |
| 2019-03-27 | BYOMass | Juvenescence investment in Venture Round - BYOMass | 1.5 M USD |
| 2019-02-04 | BHB Therapeutics | Juvenescence investment in Venture Round - BHB Therapeutics | 3 M USD |
| 2018-09-04 | AgeX Therapeutics | Juvenescence investment in Private Equity Round - AgeX Therapeutics | 43.2 M USD |
| 2018-08-06 | Napa Therapeutics | Juvenescence investment in Venture Round - Napa Therapeutics | 3 M USD |
| 2018-07-12 | FoxBio | Juvenescence investment in Venture Round - FoxBio | 10 M USD |
| 2018-06-18 | Insilico Medicine | Juvenescence investment in Series A - Insilico Medicine | 6 M USD |